Tilray Medical

Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
Tilray Medical Joins Fight Against Deadly Brain Tumors, Here's What's Happening
Italians To Enjoy Medical Marijuana Offerings From One Of The Biggest Cannabis Companies In The World

Tilray Medical Recent News

Tilray's Medical Cannabis Oral Solution Approved For Pharmaceutical Distribution In Italy
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s
Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program
Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa
Tilray Medical Launches Cannabis Education Platform 'WeCare-MedicalCannabis' Across Europe
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, launched a new cannabis education platform, WeCare-MedicalCannabis, dedicated to providing resources and educa
Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.
Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada
Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use.